Table 1.
Characteristics of the study population
| Characteristic | Study population N = 2933 | Data missing n (%) |
|---|---|---|
| Age (years), mean ± SD | 64.0 ± 10.5 | 2 (0.1) |
| BMI (kg/m²), mean ± SD | 26.9 ± 4.1 | 99 (3.4) |
| Parity, median (IQR) | 2 (1) | 47 (1.6) |
| Current smoker, n (%) | 255 (8.7) | 11 (0.4) |
| Diabetes, n (%) | 283 (9.6) | 0 |
| Prior hysterectomy, n (%) | 981 (33.4) | 0 |
| Prior POP surgery, n (%) | 740 (25.2) | 0 |
| Prior anti-incontinence surgery, n (%) | 170 (5.8) | 0 |
| POP-Q point Ba ≥ 0, n (%) | 1859 (65.5) | 96 (3.3) |
| POP-Q point C ≥ 0, n (%) | 1138 (40.6) | 130 (4.4) |
| POP-Q point Bp ≥ 0, n (%) | 1259 (44.5) | 105 (3.6) |
| PFDI-20 score, mean ± SD | 99.1 ± 49.9 | 5 (0.2) |
| OAB medication, n (%) | 97 (3.3) | 0 |
| Local or systemic estrogen therapy, n (%) | 2429 (82.9) | 4 (0.1) |
| Type of surgery, n (%) | 0 | |
| Native tissue repair | 2357 (80.4) | |
| Vaginal mesh | 362 (12.3) | |
| Abdominal mesh | 214 (7.3) |
SD, standard deviation; BMI, body mass index; IQR, interquartile range; POP, pelvic organ prolapse; POP-Q, Pelvic Organ Prolapse Quantification System; PFDI-20, Pelvic Floor Distress Inventory-20; OAB, overactive bladder